Large American companies believe that – after major countries tend to coexist with the global pandemic virus – they can find a way to entice their employees and workers to return to their offices. The officials of these companies believe that returning to the offices is the best way to provide the necessary training for new employees. It is also the best way to enhance the team spirit of the company's work. But they say they want to spend more money to build state-of-the-art headquarters that could make that return palatable to workers, even though many companies' executives see "work from home" — a pattern created by the difficulty of working from the office in the midst of the coronavirus outbreak. Novel Coronavirus – It Could Be Better for Business; Companies can even be more flexible in this regard, to maximize the benefits. The Associated Press recently indicated that more than 57% of the approximately 2,300 buildings currently being built in the United States are, in fact, buildings that began to be built last year, at the height of the epidemic attack. However, what is new in it is that these new buildings are being built, not to be offices in which the employee spends his day; Rather, they are designed so that they are places that the employee visits to cooperate with his colleagues mainly. Therefore, the new corporate headquarters were designed to include a greater number of meeting rooms, equipped with visual communication technology, so that face-to-face meetings can be held, along with visual participation.
Mutual of Omaha, an insurance company, is building what it hopes will be the tallest building in Omaha, the capital of the US state of Nebraska. Company spokesman Jim Nolan said that although the number of employees in the company reaches 4,000 people; However, the new headquarters will not accommodate more than 2,200-2,500 people. He added that the best practical solution is for the headquarters to be "hybrid". That is, capable of combining the presence and visual work at the same time.
The problem is that the number of employees working from home is increasing, despite the tangible improvement in the global health crisis. And the American Human Resources Management Association believes that the acceptance of company managers and chiefs of the results of the performance of workers from their homes during the epidemic crisis made them agree to increase the number of those wishing to work from their homes. It estimated that the total number of employees working from home will reach 36 million by 2025. The results of a survey conducted by the CBRE Group – which is the largest investment and real estate services company in the United States – indicated that 87% of large companies intend to operate according to a hybrid business model. After the end of the Corona outbreak, so that a number of employees come to the offices for a little of their time. Another survey last year reported that more than half of workers want to be back in the office for at least one day each week. Castle Systems reported that corporate executives had little success in getting their employees to work in offices; As they were unable to persuade more than 36.8% of employees to return to their offices in 10 American cities, until the fourth week of February. Executives believe that establishing the tradition of working from home will save a large amount of expenses for companies, which will spend smaller budgets on their headquarters, because there is no need for all their employees to be present at one time in their offices. Intradiam CEO Matt McConnell said that his company, which specializes in the production of electronic programs, achieved the highest profitability in its history during 2021, and did not lose any deal, despite the fact that all of its 150 employees, along with 75 contractors, all work remotely.
A promising drug.. and an Indian vaccine falters!
A British study announced that a drug for the treatment of arthritis, manufactured by the American company Eli Lilly, in cooperation with Insight, has proven to be able to reduce the risk of death by 13% and the odds of putting a patient to sleep with Covid-19. Baristinib was tested on about 8,000 people under the supervision of Oxford University scientists. The results of the experiment indicated that 546 patients who received regular health care died 28 days after confirming their infection with the virus. While death was not written except for 513 people who were prescribed parcitinib, in addition to other anti-inflammatory drugs. The experiment supervisor, Professor Peter Horby, said that the results of the experiment confirm the feasibility of using this drug, with the need to enhance it with other drugs to treat Covid-19. in Washington; The Occgen company announced yesterday that the US Food and Drug Administration refused to issue an emergency authorization to use the Covaxin vaccine, which was developed by the Indian company Bharat Biotech, to vaccinate children from two to 18 years of age. The decision led to a 30% collapse in O'Coughn's share price. However, the American company that contracted with Indian Bharat in 2020 to develop and market the Covaxin vaccine in the United States said that it will continue to work with the Food and Drug Authority to find out the conditions it must meet to obtain the desired license.
7,175 additional deaths
The Omicron mutant continued to slow the spread of its infection in the world, recording 1.46 million new cases (Saturday), accompanied by an additional 7,175 deaths. And South Korea recorded the largest number of new cases in the world, which is 243,612 injuries. While China recorded a large number of Omicron cases; The number of new infections in Hong Kong reached 37,529, with 150 additional deaths. Yesterday (Sunday), the cumulative number of injuries in the world rose to 445.60 million. In parallel, the number of deaths worldwide rose to 6.02 million.
Yassin Ahmed (London) @OKAZ_online